![]() |
![]() |
![]() |
||||||||
EXECUTIVE COMMITTEE
Chair: Harold H. Shlevin; President & CEO, Tikvah Therapeutics, Inc.
Thomas H. Callaway, MD; President, Life Science Partner, Inc.
Charles Craig; President, Georgia Bio
William D. Johnston, PhD; President, BioBusiness Strategies
Margie D. Poole; CEO, Informed Horizons, LLC
Phillip H. Street; Partner, Kilpatrick Stockton LLP
Maria Thacker; Marketing and Project Manager, Georgia Bio
PROGRAM COMMITTEE
Co-Chair: Thomas H. Callaway, MD; President, Life Science Partner, Inc.
Co-Chair: Phillip Street; Kilpatrick Stockton LLP
Bob Nerem, PhD; Professor and Director, Georgia Institute of Technology
Brenda Robbins; Senior Project Manager and Economic Development, Georgia Power
Bob McNally, PhD; President, Cell Dynamics, LLC
Margaret K. Offermann, MD, PhD; Professor of Hematology and Onocology, Emory Winship Cancer Institute
Todd Sherer, PhD; Assistant Vice President and Director of Technology Transfer, Emory University
Tim Patrick; President and CEO, Carticept Medical, Inc.
Jakob Vinten-Johansen, PhD, FAHA; Professory Cardiothoracic Surgery and Director Cardiothoracic Research Laboratory, Carlyle Fraser Heart Center
Steven Stice, PhD; Professor and GRA Eminent Scholar, University of Georgia
Bruce Robertson; Managing Director, H.I.G.
Melissa Bishop-Murphy, Esq; Director and Team Leader Government Relations and Public Affairs, Pfizer Inc.
SPONSORSHIP COMMITTEE
Chair: William Johnston; President, BioBusiness Strategies
Charles S. Craig; President, Georgia Bio
Harold Shlevin; President and CEO, Tikvah Therapeutics

